Haleon plc Stock Nyse

Equities

HLN

US4055521003

Pharmaceuticals

Market Closed - Nyse 16:00:02 2024-06-21 EDT 5-day change 1st Jan Change
8.57 USD +0.59% Intraday chart for Haleon plc +2.15% +4.13%

Financials

Sales 2024 * 11.45B 14.48B 19.83B Sales 2025 * 11.94B 15.1B 20.68B Capitalization 30.5B 38.57B 52.82B
Net income 2024 * 1.49B 1.88B 2.58B Net income 2025 * 1.71B 2.16B 2.96B EV / Sales 2024 * 3.35 x
Net Debt 2024 * 7.82B 9.88B 13.54B Net Debt 2025 * 7.06B 8.92B 12.22B EV / Sales 2025 * 3.14 x
P/E ratio 2024 *
20.7 x
P/E ratio 2025 *
17.9 x
Employees 25,408
Yield 2024 *
1.85%
Yield 2025 *
2.13%
Free-Float 81.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.59%
1 week+2.15%
Current month+1.54%
1 month+0.59%
3 months+2.88%
6 months+4.64%
Current year+4.13%
More quotes
1 week
8.30
Extreme 8.3
8.59
1 month
8.27
Extreme 8.265
8.62
Current year
7.89
Extreme 7.89
8.71
1 year
7.70
Extreme 7.695
8.96
3 years
5.59
Extreme 5.59
9.05
5 years
5.59
Extreme 5.59
9.05
10 years
5.59
Extreme 5.59
9.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 21-07-21
Director of Finance/CFO 52 21-11-30
Chief Tech/Sci/R&D Officer - 21-12-15
Members of the board TitleAgeSince
Director/Board Member - 22-07-17
Director/Board Member 64 22-07-17
Director/Board Member 57 22-07-17
More insiders
Date Price Change Volume
24-06-21 8.57 +0.59% 4,138,125
24-06-20 8.52 +0.71% 4,061,227
24-06-18 8.46 +1.08% 5,267,737
24-06-17 8.37 -0.24% 2,857,845
24-06-14 8.39 -1.06% 2,536,509

Delayed Quote Nyse, June 21, 2024 at 04:00 pm

More quotes
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.34 GBP
Average target price
3.646 GBP
Spread / Average Target
+9.18%
Consensus